Prosecution Insights
Last updated: October 04, 2026

Fondazione Istituto Italiano di Tecnologia

Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics

4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Analysis

Fondazione Istituto Italiano di Tecnologia is managing 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 3 distinct art units, which indicates that the foundation's biotechnology research is being evaluated by several different specialized technical groups. This distribution across 3 distinct art units suggests a broad research agenda that touches on multiple facets of pharmaceutical technology. The 4 pending office actions represent a significant ongoing effort to protect the foundation's technical innovations. This structure allows the foundation to receive feedback from multiple reviewers across different technical disciplines.

RUSH, ERIC is the busiest examiner for the portfolio, currently overseeing 1 pending office action. The foundation's workload is perfectly dispersed among 4 distinct examiners, with each examiner responsible for a single pending matter. This 1 to 1 ratio between 4 pending office actions and 4 distinct examiners ensures a wide variety of examiner interactions and reduces the impact of any single examiner's perspective. Such a high degree of examiner diversity across 3 distinct art units is typical for a research foundation with a varied technological output. No single examiner has a dominant influence over the foundation's pending applications.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
1
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (75%)
1
Medium (25%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (25%)
§103 only1 (25%)
Multi-statute (no §101)2 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
25% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RUSH, ERIC 1 60.8% +36.1%
LEE, SHUN K 1 42.2% +16.3%
HANEY, AMANDA MARIE 1 36.4% +44.9%
SHOMER, ISAAC 1 63.2% +30.4%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18245559 Multi-targeting cell-derived nanoparticles as a versatile theranostic SHOMER, ISAAC 22d
18712268 INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, AND PROGRAM RUSH, ERIC —
18570201 MARKER FOR DNA DAMAGE IN PROXIMITY OF TRANSCRIBED GENOMIC LOCI AND METHODS FOR IDENTIFYING AND/OR QUANTIFYING THESE DNA DAMAGES HANEY, AMANDA MARIE —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18245559 Multi-targeting cell-derived nanoparticles as a versatile theranostic SHOMER, ISAAC 22d
18712268 INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, AND PROGRAM RUSH, ERIC —
18573171 SIMULTANEOUS MULTI-SPECIES SUPER-RESOLUTION IMAGING VIA TEMPORAL MULTIPLEXING AND SINGLE- PHOTON DETECTOR ARRAY LEE, SHUN K —
18570201 MARKER FOR DNA DAMAGE IN PROXIMITY OF TRANSCRIBED GENOMIC LOCI AND METHODS FOR IDENTIFYING AND/OR QUANTIFYING THESE DNA DAMAGES HANEY, AMANDA MARIE —

Top Art Units

Art UnitApps
2884 1
1682 1
1612 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18712268 INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, AND PROGRAM RUSH, ERIC — §103§112 Non-Final OA — Pending Dec 02, 2024
18573171 SIMULTANEOUS MULTI-SPECIES SUPER-RESOLUTION IMAGING VIA TEMPORAL MULTIPLEXING AND SINGLE- PHOTON DETECTOR ARRAY LEE, SHUN K 2884 §103 Final Rejection — Pending Dec 21, 2023
18570201 MARKER FOR DNA DAMAGE IN PROXIMITY OF TRANSCRIBED GENOMIC LOCI AND METHODS FOR IDENTIFYING AND/OR QUANTIFYING THESE DNA DAMAGES HANEY, AMANDA MARIE 1682 §101§112 Final Rejection — Pending Dec 14, 2023
18245559 Multi-targeting cell-derived nanoparticles as a versatile theranostic SHOMER, ISAAC 1612 §103§112 Final Rejection 22d Pending Mar 16, 2023

Managing Fondazione Istituto Italiano di Tecnologia's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month